Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTEAB
NCT00190437Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2003
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amoxicillin + clavulanate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Duration of clinical symptoms of exacerbation. Started Aug 2003; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00190437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190437.